POMDOCTOR director discloses initial ownership

POMDOCTOR Ltd disclosed an initial ownership report for director Bao Wenqing.

Rhea-AI Filing Summary

POMDOCTOR Ltd disclosed an initial ownership report for director Bao Wenqing. The filing identifies Bao as a director of the company but shows no reported stock transactions or derivative positions, and the transaction summary indicates zero buys, sells, exercises, gifts, or other movements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the POMDOCTOR Ltd (POM) Form 3 filing show for Bao Wenqing?

The filing lists Bao Wenqing as a director of POMDOCTOR Ltd. It presents this status as the key detail and, in the provided data, does not include any specific common stock holdings, derivative positions, or other ownership entries for Bao.

Are there any stock transactions reported for Bao Wenqing in POMDOCTOR Ltd (POM)'s Form 3?

No, the Form 3 data shows no stock transactions for Bao Wenqing. The transaction summary reports zero buys, sells, exercises, gifts, tax withholdings, restructurings, and derivative transactions, indicating no trading activity is being reported in this filing.

Does the POMDOCTOR Ltd (POM) Form 3 indicate any derivative positions for Bao Wenqing?

No, the filing’s derivativeSummary is empty for Bao Wenqing. This means that, in the information provided, there are no listed options, warrants, or other derivative securities associated with Bao reported as part of this initial ownership disclosure.

How many holdings entries are disclosed for Bao Wenqing in POMDOCTOR Ltd (POM)'s Form 3?

The transaction summary shows zero holding entries for Bao Wenqing. This indicates that within the provided dataset, there are no detailed line items describing specific share amounts or classes of securities currently attributed to Bao in this filing.

What is the overall net buy or sell direction in POMDOCTOR Ltd (POM)'s Form 3 for Bao Wenqing?

The Form 3 shows a neutral net buy/sell direction for Bao Wenqing. With zero reported buys, sells, or other movements, the summarized netBuySellShares figure is zero and the netBuySellDirection field is explicitly categorized as neutral.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/30/2026 - 06:12 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bao Wenqing

(Last) (First) (Middle)

YAHUJU, AGILE GARDEN

PANYU DISTRICT

(Street)

GUANGZHOU GUANGDONG 511400

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
POMDOCTOR Ltd [ POM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Wenqing Bao	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)